SVSara Vandenwijngaert
Sara Vandenwijngaert
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sara Vandenwijngaert has a total of 434 co-authors. Here are the top co-authors by number of shared publications:
Emmanuel Buys
2 shared publicationsRobert Tainsh
2 shared publicationsAarti Asnani
1 shared publicationAdam Snook
Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, USA
1 shared publicationAdrian J. Hobbs
William Harvey Research Institute, Barts & The London School of Medicine, QMUL, London, UK
1 shared publicationAikaterini I. Argyriou
1 shared publication
Latest Publications
- Open Access
- 10 October 2017
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 18 (S1) , 1-35
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications
- 10 October 2017
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 18 (S1) , 1-35
Open AccessAbstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications
- Open Access
- 2 September 2015
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 16 (S1) , A96
Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice
- 2 September 2015
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 16 (S1) , A96
Open AccessCardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice
- 1 November 2014
- Published by Elsevier in Nitric Oxide
- Vol. 42, 120-121
A role for 20-HETE in the development of gender- and strain-specific hypertension in soluble guanylate cyclase alpha1-deficient mice
- 1 November 2014
- Published by Elsevier in Nitric Oxide
- Vol. 42, 120-121
A role for 20-HETE in the development of gender- and strain-specific hypertension in soluble guanylate cyclase alpha1-deficient mice
- 13 October 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (15) , 138
Response to Letter Regarding Article, “Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice”
- 13 October 2009
- Published by Wolters Kluwer Health in Circulation
- Vol. 120 (15) , 138
Response to Letter Regarding Article, “Ventricular Phosphodiesterase-5 Expression Is Increased in Patients With Advanced Heart Failure and Contributes to Adverse Ventricular Remodeling After Myocardial Infarction in Mice”